Abstract
Traditional gene therapy vectors have demonstrated limited utility for treatment of chronic lung diseases such as cystic fibrosis (CF). Herein we describe a vector based on a Filovirus envelope protein-pseudotyped HIV vector, which we chose after systematically evaluating multiple strategies. The vector efficiently transduces intact airway epithelium from the apical surface, as demonstrated in both in vitro and in vivo model systems. This shows the potential of pseudotyping in expanding the utility of lentiviral vectors. Pseudotyped lentiviral vectors may hold promise for the treatment of CF.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Avian Sarcoma Viruses / genetics
-
Avian Sarcoma Viruses / physiology
-
Cell Polarity
-
Cells, Cultured
-
Cystic Fibrosis / genetics
-
Cystic Fibrosis / therapy
-
Dogs
-
Ebolavirus / classification
-
Ebolavirus / genetics
-
Ebolavirus / physiology
-
Epithelium / metabolism*
-
Epithelium / virology
-
Filoviridae / classification
-
Filoviridae / genetics*
-
Filoviridae / physiology*
-
Filoviridae / ultrastructure
-
Genetic Therapy / methods
-
Genetic Vectors / genetics*
-
HIV / genetics*
-
HIV / physiology
-
HIV / ultrastructure
-
Humans
-
Lung / cytology
-
Lung / metabolism
-
Lung / virology
-
Marburgvirus / genetics
-
Marburgvirus / physiology
-
Membrane Glycoproteins*
-
Mice
-
Mice, Inbred C57BL
-
Models, Animal
-
Moloney murine leukemia virus / genetics
-
Moloney murine leukemia virus / physiology
-
Respiratory System / cytology
-
Respiratory System / metabolism*
-
Respiratory System / virology
-
Trachea / cytology
-
Trachea / metabolism
-
Trachea / virology
-
Transduction, Genetic*
-
Viral Envelope Proteins / genetics
-
Viral Envelope Proteins / metabolism
Substances
-
G protein, vesicular stomatitis virus
-
Membrane Glycoproteins
-
Viral Envelope Proteins